In this video, Dr. Gregory A. Worrell discusses the continued challenges in epilepsy care, a situation that impacts sufferers throughout all the lifespan—from infancy by older maturity. Despite accessible drugs, almost one‑third of epilepsy sufferers are drug‑resistant, persevering with to expertise seizures even with remedy. Addressing these unmet wants requires a very collaborative, group‑primarily based method.
Dr. Worrell highlights how advances in neurotechnology are reshaping the way forward for epilepsy remedy. Compared to earlier investigational gadgets, subsequent‑era implantable techniques are smaller, rechargeable, and much more succesful, leveraging speedy progress in biology, laptop chips, imaging, and synthetic intelligence.
Central to this progress is the Mayo Clinic Bionic program, which brings collectively neurologists, neurosurgeons, neuroradiologists, psychiatrists, engineers, and technologists right into a unified effort. By connecting these disciplines and accelerating innovation, the objective of Bionic is to create the following era of customized epilepsy therapies and remodel take care of sufferers who presently have restricted choices.
00:00 – The Challenge of Epilepsy Care
00:07 – Drug‑Resistant Epilepsy
00:17 – Evolution of Epilepsy Devices
00:32 – Smarter, Smaller, Rechargeable Technology
00:36 – Advances Driving Neurotechnology
00:49 – A Multidisciplinary Team Approach
01:39 – The Goal of the Bionic Program
